Namal Nawana: Sending shockwaves through Smith & Nephew

Medical devices group gets new lease of life under deal making veteran

When Namal Nawana was wooed to take the top job at Smith & Nephew, he took a hard look at the venerable UK medical devices company and found both a puzzle and an opportunity.

“The technologies themselves were often of the highest calibre. So, my initial impression was, why is a company with such great assets not perhaps performing as well as it could?” he says.

Sri Lankan-born, but his accent testament to an Australian upbringing, his amiable, low-key demeanour belies the shockwaves he has sent through the 160 year-old corporate stalwart since taking the helm 13 months ago.

Hired at a salary “multiples” less than he earned in his former job as chief executive of US diagnostics company Alere — “I genuinely like this opportunity” — he has cut a swath through the group, replacing or moving two-thirds of its senior leadership team. “I’m a believer that once you know something needs to be changed, then you change it,” he says.

Not content with personnel changes, the 48 year-old has also overhauled S&N’s operating model which had previously focused on geography rather than speciality, with separate heads for the US and international markets, but not its product franchises.

He has installed presidents for each division — sports medicine; orthopaedics and wound management — in an attempt to sharpen execution in a sector marked by constant evolution.

“The innovation cycle times [for devices] are so short, sometimes only a year . . . you need to have people who are absolutely focused, laser-focused on each of the businesses. You can’t have generalists.”

“We weren’t getting commercial results. So, in the new organisation structure, we basically divide and conquer,” he says.

Results have come quickly — a relief to investors who have long chafed at the company’s inability to match its rivals’ growth and appetite for acquisitions.

By Sarah Neville | Financial Times

Image Credit: Anna Gordon / Financial Times


About Peter Coffaro 510 Articles
Peter Coffaro is a growth-driven and strategic executive with over 25 years of progressive management success in the medical device industry. With a proven track record and recognized expertise, Peter has established himself as one of the top influencers in medical sales, as acknowledged by prestigious publications such as the World Journal of Orthopedics, Exponential Healthtech, and Throughout his career, Peter has accumulated 10 years of combined sales management experience, excelling in various roles including Director, General Manager, Distributor, and Vice President. He has worked for industry-leading orthopedic companies such as Zimmer, DePuy, and Stryker, solidifying his deep knowledge and network within the field. Peter’s passion for innovation and emerging technologies led him to found OrthoFeed, an award-winning blog covering digital orthopedic news and emerging medical technologies. Through this platform, he stays at the forefront of the industry and contributes to the dissemination of valuable insights. Peter is a three-time Hall of Fame award winner at Johnson and Johnson, demonstrating his exceptional contributions and impact on the organization. His expertise extends to areas such as organizational development, business development, sales management, digital marketing, and professional education. Peter earned a B.S. degree in Biology and Chemistry from Northern Illinois University, further complementing his comprehensive understanding of the medical field. With his wealth of experience, strategic mindset, and dedication to advancing healthcare, Peter Coffaro is a valuable asset and leader in the medical device industry.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.